Eupraxia Pharmaceuticals, Inc. (EPRX)
7.32
-0.14
(-1.88%)
USD |
NASDAQ |
Oct 12, 16:00
7.32
0.00 (0.00%)
After-Hours: 20:00
Eupraxia Pharmaceuticals Price : 7.32 for Oct. 12, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 12, 2026 | 7.46 | 7.56 | 7.250 | 7.32 | 250665.0 |
| Oct 09, 2026 | 7.57 | 7.70 | 7.275 | 7.46 | 1.052M |
| Oct 08, 2026 | 7.69 | 7.75 | 7.34 | 7.57 | 637045.0 |
| Oct 07, 2026 | 7.64 | 7.88 | 7.475 | 7.78 | 853311.0 |
| Oct 06, 2026 | 7.81 | 8.07 | 7.67 | 7.74 | 1.636M |
| Oct 05, 2026 | 7.20 | 7.93 | 7.07 | 7.745 | 1.775M |
| Oct 02, 2026 | 8.00 | 8.09 | 7.19 | 7.24 | 1.714M |
| Oct 01, 2026 | 8.91 | 9.12 | 7.68 | 7.83 | 3.645M |
| Sep 30, 2026 | 8.33 | 9.21 | 8.125 | 9.10 | 1.279M |
| Sep 29, 2026 | 8.16 | 8.46 | 8.08 | 8.305 | 645109.0 |
| Sep 28, 2026 | 7.84 | 8.22 | 7.84 | 8.21 | 369124.0 |
| Sep 25, 2026 | 8.19 | 8.30 | 7.86 | 8.01 | 1.313M |
| Sep 24, 2026 | 8.35 | 8.35 | 7.841 | 8.16 | 452919.0 |
| Sep 23, 2026 | 8.55 | 8.605 | 7.98 | 8.14 | 662592.0 |
| Sep 22, 2026 | 8.77 | 8.77 | 8.39 | 8.58 | 781668.0 |
| Sep 21, 2026 | 8.73 | 8.77 | 8.51 | 8.64 | 314186.0 |
| Sep 18, 2026 | 8.37 | 8.715 | 8.37 | 8.58 | 555036.0 |
| Sep 17, 2026 | 8.30 | 8.425 | 8.259 | 8.38 | 257874.0 |
| Sep 16, 2026 | 8.12 | 8.25 | 8.00 | 8.09 | 197604.0 |
| Sep 15, 2026 | 8.05 | 8.14 | 7.93 | 8.11 | 197828.0 |
| Sep 14, 2026 | 8.32 | 8.365 | 8.00 | 8.07 | 432122.0 |
| Sep 11, 2026 | 8.14 | 8.49 | 8.11 | 8.42 | 492925.0 |
| Sep 10, 2026 | 7.95 | 8.30 | 7.840 | 8.02 | 260914.0 |
| Sep 09, 2026 | 8.18 | 8.33 | 8.00 | 8.08 | 186534.0 |
| Sep 08, 2026 | 8.42 | 8.60 | 8.22 | 8.25 | 375211.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Edesa Biotech, Inc. | 2.94 |
| ProMIS Neurosciences, Inc. | 9.45 |
| Arrowhead Pharmaceuticals, Inc. | 60.73 |
| Oncolytics Biotech, Inc. | 0.4733 |
| Sangamo Therapeutics, Inc. | 0.15 |
Price Related Metrics
| PEG Ratio | -0.4527 |
| Price to Book Value | 4.710 |
| Earnings Yield | -13.45% |
| Market Cap | 479.27M |
| PEGY Ratio | -0.4527 |